BioPorto A/S
BIOPOR
Rang in aandelen
#22955
BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker... BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker tests, research tools, and antibodies to medical professionals and scientists worldwide, with operations across Europe, North America, and Asia. Among its offerings is the neutrophil gelatinase-associated lipocalin (NGAL) test, a precise quantitative particle-enhanced turbidimetric immunoassay designed for use on automated chemistry analyzers. The company further provides monoclonal antibodies essential for scientific, pharmaceutical, and clinical investigations. Additionally, BioPorto produces enzyme-linked immunosorbent assay (ELISA) kits and a versatile rapid assay device tailored for custom lateral flow assay development. Established in 1917, the company is headquartered in Hellerup, Denmark.
Aandeelprijs
$0.15400149
Laatst gesynchroniseerd: 2026-10-21
Marktkapitalisatie
$76.25M
Verandering (1 dag)
-5.83%
Verandering (1 jaar)
-46.53%
Land
DK
Handel BioPorto A/S (BIOPOR)
Categorie
Healthcare
Koersgeschiedenis voor BioPorto A/S (BIOPOR)
Hoogste slotkoers: $0.15 op 2026-10-01
Laagste slotkoers: $0.41 op 2019-12-01
Laagste slotkoers: $0.41 op 2019-12-01
Koersgeschiedenis van BioPorto A/S van 2019 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | -35.46% |
| 2025 | 0.00% |
| 2024 | -28.16% |
| 2023 | -37.74% |
| 2022 | -14.14% |
| 2021 | 106.94% |
| 2020 | -11.60% |
| 2019 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.90 | 54.69% |
CN
|
|
| $177.93 | 21.98% |
US
|
